Stock DOSEF DOSEOLOGY SCIENCES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Doseology Sciences Inc. OTC Markets

Equities

DOSEF

CA2584842033

Pharmaceuticals

Market Closed - OTC Markets
Other stock markets
 03:12:56 2024-05-02 pm EDT 		5-day change 1st Jan Change
0.3096 USD +126.81% Intraday chart for Doseology Sciences Inc. +126.81% +38.21%
2023 Doseology Sciences Inc. Announces CFO Changes CI
2023 Doseology Sciences Inc. Announces CEO Changes CI

Business Summary

Lucy Scientific Discovery Inc., formerly Doseology Sciences Inc., is an early-stage psychedelic manufacturing company. The Company is focused on research, development and manufacturing for the emerging psychedelic-based medicine industry. The Company is advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies, medicines, and commercial products. It is engaged in developing consumer product manufacturing, marketing and distribution. The Company is dedicated to the production of a variety of natural, synthetic and biosynthetic products to meet the needs of the psychotropics-based medicine market.

Sales per Business

CAD in Million2022Weight2023Weight Delta
Functional Mushroom Products
100.0 %
0 100.0 % 0 100.0 % +168.49%

Sales per region

CAD in Million2022Weight2023Weight Delta
Canada
97.0 %
0 100.0 % 0 97.0 % +160.44%
United States
3.0 %
-- 0 3.0 % -

Managers

Managers TitleAgeSince
Daniel Vice FOU
 Founder 35 19-10-09
Shawn Balaghi CEO
 Chief Executive Officer 55 23-05-04
Basin CTO
 Chief Tech/Sci/R&D Officer - -
Scott Reeves BRD
 Director/Board Member 55 20-05-26
Lindsay Hamelin SEC
 Corporate Secretary 37 23-05-04

Members of the board

Members of the board TitleAgeSince
Scott Reeves BRD
 Director/Board Member 55 20-05-26
Shawn Balaghi CEO
 Chief Executive Officer 55 23-05-04
Daniel Vice FOU
 Founder 35 19-10-09

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 4,400,515 4,227,515 ( 96.07 %) 0 96.07 %

Shareholders

NameEquities%Valuation
Scott Reeves
1.875 %
82,500 1.875 % 41 745 $
Daniel Vice
1.852 %
81,500 1.852 % 41 239 $
David Lutz
0.1136 %
5,000 0.1136 % 2 530 $
Shawn Balaghi
0.0909 %
4,000 0.0909 % 2 024 $
Pratik Patel
0.000000 %
0 0.000000 % - $

Company contact information

Doseology Sciences, Inc.

9-3151 Lakeshore Road Unit 305

V1W 3S9, Kelowna

+236 349 0064

http://www.doseology.com
address Doseology Sciences Inc.(DOSEF)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.65% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 194B
AMGEN INC. Stock Amgen Inc.
+8.08% 167B
PFIZER, INC. Stock Pfizer, Inc.
-3.40% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. MOOD Stock
  4. DOSEF Stock
  5. Company Doseology Sciences Inc.